Cargando…
Crosstalk between glioblastoma and tumor microenvironment drives proneural–mesenchymal transition through ligand-receptor interactions
Glioblastoma (GBM) is the most common intrinsic and aggressive primary brain tumor in adults, with a median survival of approximately 15 months. GBM heterogeneity is considered responsible for the treatment resistance and unfavorable prognosis. Proneural-mesenchymal transition (PMT) represents GBM m...
Autores principales: | Lai, Yancheng, Lu, Xiaole, Liao, Yankai, Ouyang, Pei, Wang, Hai, Zhang, Xian, Huang, Guanglong, Qi, Songtao, Li, Yaomin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491977/ https://www.ncbi.nlm.nih.gov/pubmed/37692522 http://dx.doi.org/10.1016/j.gendis.2023.05.025 |
Ejemplares similares
-
ME2 Promotes Proneural–Mesenchymal Transition and Lipogenesis in Glioblastoma
por: Yang, Mengting, et al.
Publicado: (2021) -
Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma
por: Fedele, Monica, et al.
Publicado: (2019) -
Altered cytoskeletal status in the transition from proneural to mesenchymal glioblastoma subtypes
por: Keller, Maureen, et al.
Publicado: (2022) -
Monocyte depletion enhances neutrophil influx and proneural to mesenchymal transition in glioblastoma
por: Chen, Zhihong, et al.
Publicado: (2023) -
USP10 deubiquitinates RUNX1 and promotes proneural-to-mesenchymal transition in glioblastoma
por: Qiu, Wenjin, et al.
Publicado: (2023)